Shaping the Future of Advanced Therapies
PQP is excited to attend the Cell & Gene Meeting on the Mesa 2026, taking place October 5–7 in Phoenix, Arizona. As one of the sector’s largest and most influential gatherings, the event draws over 1,500 global leaders, with more than 30% at the C-suite level. From clinical development and regulatory strategy to manufacturing scale-up, supply chain innovation, investment, and patient access, the conference spans the entire cell and gene therapy value chain.
Navigating Complexity from Bench to Bedside
As advanced therapies move from scientific promise to commercial reality, organizations are navigating increasingly complex challenges, including novel clinical trial designs, evolving payment and reimbursement models, manufacturing readiness, and the infrastructure needed to deliver therapies at scale.
PQP’s Focus Areas at the Event
At Meeting on the Mesa, PQP looks forward to connecting with therapy developers, biopharma companies, CDMOs, investors, and technology providers. Our team will be engaging in discussions on:Clinical development and regulatory strategy
- Manufacturing scale-up and operational readiness
- Quality and compliance across the product lifecycle
- Commercialization and market access challenges
- Supply chain and logistics solutions for advanced therapies
- Investment trends and partnership opportunities
- Innovations accelerating patient access to cell and gene therapies
Connect with Our Team in Phoenix
With thousands of one-on-one partnering meetings and conversations spanning the full advanced therapies ecosystem, the event offers an unparalleled forum for collaboration and knowledge sharing.
Attending this year? We would be delighted to connect. Visit us at the floor or get in touch to arrange a meeting with our team in advance.
